4//SEC Filing
O'Connor Daniel J. 4
Accession 0000950170-23-032232
CIK 0001836056other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:06 PM ET
Size
5.8 KB
Accession
0000950170-23-032232
Insider Transaction Report
Form 4
O'Connor Daniel
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2023-07-05+1,216,500→ 1,216,500 totalExercise: $2.38Exp: 2033-07-05→ Ordinary Shares (1,216,500 underlying)
Footnotes (3)
- [F1]The options will have an exercise price per share equal to the fair market value per ordinary share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").
- [F2]1/6 of the Ordinary Shares subject to the option vest on January 5, 2024, and the remainder vests in ten (10) equal quarterly installments following such date.
- [F3]The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents seven Ordinary Shares of the Issuer.
Documents
Issuer
Ambrx Biopharma Inc.
CIK 0001836056
Entity typeother
Related Parties
1- filerCIK 0001376847
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 4:06 PM ET
- Size
- 5.8 KB